Novartis in record Swiss deal
Pharmaceuticals company Novartis is acquiring a potential US$ 39bn (
Pharma
Changes in pharma CFOs roles: Ernst & Young survey
A latest Ernst & Young survey of Chief financial officers (CFOs) in the Indian pharmaceutical sector underscores important changes in the role of the CFO and the finance function in driving the success of pharmaceutical companies. Respondents of the India CFO survey envisaged a change in their responsibilities, with an increased focus on serving as business partners and managing growth.
ALERT project looks to ICT for drug safety
A new EU-funded information and communication technology (ICT) project is tackling issues of safety in newly developed drugs. Over the next three and a half years, the ALERT (‘Early detection of adverse drug events by integrative mining of clinical records and biomedical knowledge’) project partners will work on an innovative computer system for a better and faster detection of adverse drug reactions (ADRs).
Pharma RFID market expected to hit US$ 1 trillion by 2020
The market for Radio Frequency Identification, or RFID, applications in pharmaceuticals is conservatively estimated to reach US$ 600 million by 2012 with a compound annual growth rate of 60 percent, according to a new market research study.
Suven Life with Eli Lilly for research
Pharmaceutical firm Suven Life Sciences has signed an agreement with US-based Eli Lilly to collaborate on the pre-clinical research of molecules used in the treatment of Central Nervous System(CNS) disorders.
Quintiles central lab (India) receives CAP certification
Quintiles Transnational Corp. has announced that its central laboratory in India has been certified by the College of American Pathologists (CAP).
Cirrius Wireless designs marketing network for pharma giant
Pharmaceutical firm Merck Ltd announced recently that it has partnered with software firm Cirrius Wireless Technologies for providing mobile-based solution, marketing network and activation system (MANAS) to its sales representatives across the country.
Wockhardt hiving off R&D business
Drug maker Wockhardt has announced it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. The company thus has followed similar moves by other pharma companies, who have hived off their research and development units.
Blogs new window to the world for Pharma industry
Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.
Cellworks in collaboration with Orchid on drug discovery
Cellworks Research India, the Bangalore-based research and development (R&D) wing of Cellworks Group Inc (California-headquartered company), has assisted Chennai-based Orchid Chemicals and Pharmaceuticals by providing system biology technology in carrying out ongoing New Chemical Entity (NCE) research programme.
Breakthrough in cardiac pharmacology
PhysioStim of France, a specialist in cardiac safety pharmacology, is setting up a new model for isolated cardiomyocytes, which will record all types of ionic currents and action potentials.
Alved Pharma goes to ICICI Ventures for INR 30 cr
Private equity (PE) major ICICI Ventures is acquiring Chennai-based standalone pharmaceutical and
veterinary company Alved Pharma and Foods. RFCL, a wholly-owned veterinary, chemicals and medical
diagnostic company of ICICI Ventures, is learnt to have signed a definitive agreement with Alved Pharma and Foods for a complete buyout.
